This week, Pfizer announced another major investment in manufacturing capacity in the United States. Its investment in a new facility is focused on tackling the unique challenges in manufacturing gene therapies. We also look at the possibility of replacing glasses with eye drops, crowdsourcing cancer ... READ MORE >
vaccines
Defense technology companies contend with supply chain challenges, vaccine mandate
Companies in the defense technologies ecosystem continue to closely monitor and optimize their labor force and supply chains while positioning for short- and long-term federal government modernization and innovation efforts. In third-quarter earnings calls, top industry executives primarily addressed ... READ MORE >